Analyses / Impact Analysis / 119 · SJRES 82 Impact Analysis

119-SJRES-82 Investigative Journalist Impact Analysis

119 · SJRES 82 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Office of the Secretary of the Department of Health and Human Services relating to "Policy on Adhering to the Text of the Administrative Procedure Act".

Bottom-line assessment
Analytical stance based on documented trade‑offs.
CRA disapprovals enacted since 1996
20rules
Median duration: rules with extended comment vs. without
2.1years vs. 0.96 years
FDA estimate for a straightforward rule (initiation → final)
3.8years (approx.)
Published
24 Oct 2025
Updated
24 Oct 2025
Tags
Impact analysis · Congressional Review Act · HHS
Unvetted
01 · Section

Summary

What the resolution does. S.J.Res. 82 invokes the Congressional Review Act (CRA) to disapprove HHS’s March 3, 2025 policy statement “Policy on Adhering to the Text of the Administrative Procedure Act,” which had rescinded the Department’s 1971 Public Participation policy (the Richardson Waiver) and allowed APA §553(a)(2)-exempt matters (public property, loans, grants, benefits, contracts; agency management/personnel) to proceed without notice‑and‑comment. GAO determined the policy is a “rule” for CRA purposes, enabling congressional disapproval. [1]Justia (Federal Register mirror) — Federal Register notice: Policy on Adhering…[2]U.S. Government Accountability Office — GAO Decision B‑337397: Applicability of…

Likely legal effect if enacted. A CRA disapproval would void the HHS policy and, as a practical matter, return the status quo ante; CRA also bars an agency from issuing a rule that is “substantially the same” as the disapproved rule absent new statutory authorization. The phrase is undefined in the statute, creating long‑term uncertainty about how far HHS could go to re‑adopt similar internal rulemaking policies. [4]Congressional Research Service — CRS In Focus IF10023: The Congressional Review…

02 · Section

Economic Effects

Direct market effects are limited because the measure targets process, not program funding. Still, process changes at HHS can alter timing, predictability, and compliance costs for grant recipients, contractors, and regulated health sectors.

  • Administrative cost/time. Reinstating the Richardson Waiver would require more notice‑and‑comment proceedings for §553(a)(2) categories, reversing HHS’s 2025 process streamlining that HHS itself said imposed extra costs when in place. Expect added staff time to draft NPRMs, analyze comments, and build records. [1]Justia (Federal Register mirror) — Federal Register notice: Policy on Adhering…
  • Timeline impacts. Empirical work and GAO case studies show rulemakings with extended comment periods take longer; FDA officials estimate even straightforward rules can take ~3.5–4 years from initiation to final publication. Reimposing notice‑and‑comment on more actions likely lengthens cycles for grant terms, benefits administration policies, and contracting rules. [5]The Regulatory Review (Penn Program on Regulation) — Does Extending a Comment P…[6]U.S. Government Accountability Office — GAO-09-205: Federal Rulemaking—Timeline…
  • Predictability/record quality. Expanded public participation generally improves the quality, legitimacy, and accountability of agency decisions, which can reduce policy volatility and help withstand subsequent policy swings. [7]The Regulatory Review (Penn Program on Regulation) — Public Engagement in Rulem…
  • Scope constraints. Many high‑impact HHS areas (for example, Medicare policies establishing or changing substantive legal standards) already must use notice‑and‑comment under separate statutes; for these domains, S.J.Res. 82 may produce little incremental burden beyond current law. [8]Arnold & Porter (advisory) — HHS Rescinds Longstanding Policy Requiring Notice…
  • Transaction costs for stakeholders. Providers, manufacturers, universities, and nonprofits gain more formal opportunities to shape rules affecting grants, benefits, and contracting, but must invest more in monitoring and commenting—costs that favor sophisticated actors. [7]The Regulatory Review (Penn Program on Regulation) — Public Engagement in Rulem…
CRA disapprovals enacted since 1996
20rules
Median duration: rules with extended comment vs. without
2.1years vs. 0.96 years
FDA estimate for a straightforward rule (initiation → final)
3.8years (approx.)
03 · Section

Social Effects

Process changes shape who has voice in health policy and how quickly policy can adapt.

  • Public participation restored. Disapproval would re‑expand formal comment opportunities on grants/benefits/contracting policies, creating additional channels for patients, providers, tribes, and community organizations—groups often underrepresented outside notice‑and‑comment. [1]Justia (Federal Register mirror) — Federal Register notice: Policy on Adhering…[9]Web search · turn 9 #2
  • Transparency and legitimacy. Greater engagement typically enhances perceived legitimacy and yields richer records; ACUS recommends maintaining robust participation even when agencies use expedited tools. [10]Web search · turn 9 #3
  • Equity dynamics. More formal process can help surface impacts on underserved communities—but participation costs (time, expertise) can skew inputs toward well‑resourced organizations unless agencies proactively broaden outreach. [7]The Regulatory Review (Penn Program on Regulation) — Public Engagement in Rulem…
  • Service delivery timing. Slower policy turnarounds for program guidance and grant conditions may delay implementation of changes aimed at beneficiaries (e.g., adjustments to award terms, eligibility clarifications), trading speed for deliberation. [6]U.S. Government Accountability Office — GAO-09-205: Federal Rulemaking—Timeline…
04 · Section

Environmental Effects

Direct environmental impacts are minimal; effects are indirect via public‑health programs and research funding that may address environmental determinants of health.

  • If more HHS policies undergo notice‑and‑comment, communities could have greater input on program rules that touch environmental health (e.g., grants addressing lead exposure or toxic substances), potentially improving program design; any emissions/resource effects would be second‑order and case‑specific. (No direct statutory environmental provisions are at issue.)
05 · Section

Temporal Analysis

Horizon Likely outcomes
Immediate (enactment + 0–6 months) HHS policy voided and treated as never in effect; agencies likely revert to prior practice (Richardson Waiver) for §553(a)(2) categories; new/revised actions queued for NPRMs where applicable. [4]Congressional Research Service — CRS In Focus IF10023: The Congressional Review…
Near term (6–18 months) Increased volume of notices and comment periods for grants/benefits/contracting and internal management rules; slower effective dates but more stakeholder input and record‑building. [6]U.S. Government Accountability Office — GAO-09-205: Federal Rulemaking—Timeline…
Long term (18+ months) Persistent constraint: HHS cannot issue a policy “substantially the same” absent new law; ambiguity over that standard may chill future attempts to streamline process. Program areas already subject to independent N&C mandates see little change. [3]Congressional Research Service — CRS Report R43992: The Congressional Review Ac…[8]Arnold & Porter (advisory) — HHS Rescinds Longstanding Policy Requiring Notice…
06 · Section

Unintended Consequences

Risks and second‑order effects documented in authoritative sources.

  • Substantially‑the‑same bar. CRA’s prohibition on re‑issuing “substantially the same” rules is undefined and largely insulated from judicial review, creating uncertainty that could deter even modest procedural updates at HHS. [3]Congressional Research Service — CRS Report R43992: The Congressional Review Ac…
  • Status‑quo‑ante complexities. While CRA commonly restores the pre‑rule baseline, details can depend on how the rescinded policy interacted with prior issuances; agencies may need clarifying guidance to avoid gaps or duplicative notices. [11]Web search · turn 7 #1
  • Capacity strain. Requiring N&C for more actions without added resources can slow program adjustments (e.g., grant conditions, administrative standards), imposing opportunity costs on time‑sensitive initiatives. [6]U.S. Government Accountability Office — GAO-09-205: Federal Rulemaking—Timeline…
  • Participation imbalance. Expanded formal process may amplify organized interests unless agencies adopt outreach best practices identified by ACUS and OIRA. [9]Web search · turn 9 #2
07 · Section

Assessment

Analytical stance based on documented trade‑offs.

Overall stance: Neutral. Disapproval would trade speed and administrative flexibility for greater transparency, stakeholder input, and record quality. Where other statutes already require notice‑and‑comment (e.g., significant Medicare policies), marginal effects are modest; elsewhere, expect slower cycles and higher process costs but potentially more durable policies. Given CRA’s bar on re‑issuing substantially similar rules, the resolution would lock in a more participatory posture at HHS until Congress directs otherwise. [8]Arnold & Porter (advisory) — HHS Rescinds Longstanding Policy Requiring Notice…[3]Congressional Research Service — CRS Report R43992: The Congressional Review Ac…

08 · Section

Sourcing

Key primary and analytical references underpinning this assessment.

  • HHS policy text and rationale (Federal Register excerpt). [1]Justia (Federal Register mirror) — Federal Register notice: Policy on Adhering…
  • GAO decision finding the HHS policy a CRA‑covered rule; Congressional Record printing. [2]U.S. Government Accountability Office — GAO Decision B‑337397: Applicability of…[12]Congress.gov / Library of Congress — Congressional Record (Sept. 3, 2025): Prin…
  • CRA mechanics and effects (CRS FAQs and brief). [3]Congressional Research Service — CRS Report R43992: The Congressional Review Ac…[4]Congressional Research Service — CRS In Focus IF10023: The Congressional Review…
  • Rulemaking timelines and comment‑period effects (GAO report; empirical analysis). [6]U.S. Government Accountability Office — GAO-09-205: Federal Rulemaking—Timeline…[5]The Regulatory Review (Penn Program on Regulation) — Does Extending a Comment P…
  • Program‑specific constraints (e.g., Medicare) where separate statutes already mandate notice‑and‑comment. [8]Arnold & Porter (advisory) — HHS Rescinds Longstanding Policy Requiring Notice…
  • Bill status overview for S.J.Res. 82. [13]Congress.gov / Library of Congress — S.J.Res. 82 (119th Congress) — bill overvi…
Sources cited
  1. [1] Federal Register notice: Policy on Adhering to the Text of the Administrative Procedure Act (FR Doc. 2025‑03300) Justia (Federal Register mirror)
  2. [2] GAO Decision B‑337397: Applicability of the CRA to HHS Policy on Adhering to the Text of the APA (Aug. 27, 2025) U.S. Government Accountability Office
  3. [3] CRS Report R43992: The Congressional Review Act (CRA): Frequently Asked Questions Congressional Research Service
  4. [4] CRS In Focus IF10023: The Congressional Review Act (CRA): A Brief Overview Congressional Research Service
  5. [5] Does Extending a Comment Period Equal Regulatory Delay? The Regulatory Review (Penn Program on Regulation)
  6. [6] GAO-09-205: Federal Rulemaking—Timelines and transparency issues in OMB reviews U.S. Government Accountability Office
  7. [7] Public Engagement in Rulemaking (Sant’Ambrogio & Staszewski) The Regulatory Review (Penn Program on Regulation)
  8. [8] HHS Rescinds Longstanding Policy Requiring Notice of Certain Regulatory and Policy Changes Arnold & Porter (advisory)
  9. [9] Web search · turn 9 #2
  10. [10] Web search · turn 9 #3
  11. [11] Web search · turn 7 #1
  12. [12] Congressional Record (Sept. 3, 2025): Printing of GAO Decision B‑337397 at S6003–S6005 Congress.gov / Library of Congress
  13. [13] S.J.Res. 82 (119th Congress) — bill overview Congress.gov / Library of Congress

Discussion